Missedย NVDA?
Donโt Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ Chain Bridge I (CBRG) Stock Forecast & Price Prediction United States | NASDAQ | Financial Services | Shell Companies
$11.02
+0.00 (0.00%)Did CBRG Make This Month's Elite Buy List?
We don't follow just any analyst โ only the top 3% with a proven track record make our cut. See if Chain Bridge I is one of their latest high-conviction picks.
CBRG has shown a year-to-date change of 0.0% and a 1-year change of 0.0%, reflecting flat performance over the past year. Comprehensive analyst forecasts are currently unavailable for CBRG. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for CBRG.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|
The following stocks are similar to Chain Bridge I based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ tracked and updated every Monday and Thursday.
Special purpose acquisition company seeking mergers.
Chain Bridge I operates as a special purpose acquisition company (SPAC), focusing on merging with businesses across various sectors, including technology, software, biotechnology, and traditional industries like healthcare and industrials. The company generates value for investors by identifying and acquiring target companies, thus facilitating their growth and operational expansion.
Incorporated in 2021 and based in Dover, Delaware, Chain Bridge I is positioned to capitalize on diverse market opportunities through strategic acquisitions, although it currently has no significant operations.
Financial Services
Shell Companies
0
Mr. Andrew Cohen
United States
2022
Phytanix Bio, a preclinical pharmaceutical firm focused on cannabinoid therapeutics, has released a new investor deck as of July 30, 2024.
Phytanix Bio's release of an investor deck signals potential growth and funding opportunities in the cannabinoid pharmaceutical sector, attracting interest and investment in emerging therapies.
Chain Bridge I is acquiring Phytanix Bio, forming a new public company aimed at developing next-generation cannabinoid and cannabinoid-like medicines.
The acquisition signals potential growth in the cannabinoid market, attracting investor interest in innovative healthcare solutions and expanding portfolio opportunities.
Analyst forecasts for Chain Bridge I (CBRG) are not currently available. The stock is trading at $11.02.
Analyst ratings for CBRG are not currently available. The stock is currently trading at $11.02. Investment decisions should be based on thorough research and your personal financial goals. Always conduct your own research and consider your investment goals before making investment decisions.
Price predictions from Wall Street analysts for CBRG are not currently available. The stock is trading at $11.02.
Chain Bridge I operates as a special purpose acquisition company (SPAC), focusing on merging with businesses across various sectors, including technology, software, biotechnology, and traditional industries like healthcare and industrials. The company generates value for investors by identifying and acquiring target companies, thus facilitating their growth and operational expansion.
Price targets from Wall Street analysts for CBRG are not currently available. The stock is trading at $11.02.
Price targets from Wall Street analysts for CBRG are not currently available. The stock is trading at $11.02.
Analyst ratings for CBRG are not currently available. The stock is trading at $11.02.
Stock price projections, including those for Chain Bridge I, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.